Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Dopamine Plasma Membrane Transport Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine D4 receptor polymorphism < Dopamine Plasma Membrane Transport Proteins < Dopamine Plasma Membrane Transport Proteins (antagonists & inhibitors)  Facettes :

List of bibliographic references indexed by Dopamine Plasma Membrane Transport Proteins

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
003423 (2006) Angelo Antonini [Italie] ; Stefano Goldwurm [Italie] ; Riccardo Benti [Italie] ; Holger Prokisch [Allemagne] ; Monika Ebhardt [Allemagne] ; Roberto Cilia [Italie] ; Michela Zini [Italie] ; Andrea Righini [Italie] ; Giovanni Cossu [Italie] ; Gianni Pezzoli [Italie]Genetic, clinical, and imaging characterization of one patient with late‐onset, slowly progressive, pantothenate kinase‐associated neurodegeneration
003709 (2005) Paul Morrish [Royaume-Uni]The meaning of negative DAT SPECT and F‐Dopa PET scans in patients with clinical Parkinson's disease
003948 (2005) Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]Dopaminergic innervation of the human striatum in Parkinson's disease
003B82 (2004) Sarah Furtado [Canada] ; Haydeh Payami [États-Unis] ; Paul J. Lockhart [États-Unis] ; Melissa Hanson [États-Unis] ; John G. Nutt [États-Unis] ; Andrew A. Singleton [États-Unis] ; Amanda Singleton [États-Unis] ; Jamel Bower [États-Unis] ; Ryan J. Utti [États-Unis] ; Thomas D. Bird [États-Unis] ; Raul De La Fuente-Fernandez [Canada] ; Yoshio Tsuboi [États-Unis] ; Mary L. Klimek [Canada] ; Oksana Suchowersky [Canada] ; John Hardy [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; A. Jon Stoessl [Canada]Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2)
003B87 (2004) Rainer Linke [Allemagne] ; Ilonka Eisensehr [Allemagne] ; Thomas-Christian Wetter [Allemagne] ; Franz-Josef Gildehaus [Allemagne] ; Gabriele Pöpperl [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Soheyl Noachtar [Allemagne] ; Klaus Tatsch [Allemagne]Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease?
003C63 (2004) Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
003C91 (2004) Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne]Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes
003D30 (2004) William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdulah Sherzai [États-Unis] ; Antonella Favit [États-Unis] ; M. M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis]Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease
003E30 (2004) Sylvia M. Boesch [Autriche] ; Eveline Donnemiller [Autriche] ; Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study
003F10 (2003) Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
003F52 (2003) Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]Role of dopamine transporter imaging in routine clinical practice
003F53 (2003) Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
003F54 (2003) Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne]Role of dopamine transporter SPECT for the practitioner and the general neurologist
003F84 (2003) Hani T. S. Benamer [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Oliver Pogarell [Allemagne] ; H. Höffken [Allemagne] ; A. Gerstner [Allemagne] ; Donald G. Grosset [Royaume-Uni]Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations
004008 (2003) Maria Bozi [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Paroxysmal exercise‐induced dystonia as a presenting feature of young‐onset Parkinson's disease
004041 (2003) Walter Pirker [Autriche] ; Iris Holler [Autriche] ; Willibald Gerschlager [Autriche] ; Susanne Asenbaum [Autriche] ; Georg Zettinig [Autriche] ; Thomas Brücke [Autriche]Measuring the rate of progression of Parkinson's disease over a 5‐year period with β‐CIT SPECT
004056 (2003) David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis]Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT‐1 in striatum of asymptomatic volunteers and patients with Parkinson's disease
004118 (2003) George R. Uhl [États-Unis]Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism
004119 (2003) Paola P. Piccini [Royaume-Uni]Dopamine transporter: Basic aspects and neuroimaging
004120 (2003) Andrew Lees (neurologue) [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Dopamine transporter imaging
004121 (2003) Richard C. Dodel [Allemagne] ; Helmut Höffken [Allemagne] ; J. Carsten Möller [Allemagne] ; Bernhard Bornschein [Allemagne] ; Thomas Klockgether [Allemagne] ; Thomas Behr [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Uwe Siebert [États-Unis, Allemagne]Dopamine transporter imaging and SPECT in diagnostic work‐up of Parkinson's disease: A decision‐analytic approach

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Plasma Membrane Transport Proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Plasma Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Plasma Membrane Transport Proteins
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024